References
- Becker KL, Snider R, Nylen ES. Procalcitonin in sepsis and systemic inflammation: A harmful biomarker and a therapeutic target. Br J Pharmacol 2010; 159: 253–264
- Gilbert DN. Use of plasma procalcitonin levels as an adjunct to clinical microbiology. J Clin Microbiol 2010; 48: 2325–2329
- Cho SY, Lee A, Lee HJ, Suh JT, Park TS, Mean platelet volume in Korean patients with hepatic diseases. Platelet 2012 (accepted for publication)
- Cho SY, Jeon YL, Lee HJ, Suh JT, Park TS, Mean platelet volume in Korean patients with acute ischemic stroke: A gender difference. Platelet 2012 Mar 2. [Epub ahead of print]
- Cho SY, Suh JS, Cho BS, Lee WI, Lee HJ, Suh JT, Park TS, Mean platelet volume in pediatric chronic kidney diseases. Platelet 2012 (accepted for publication)
- Chu SG, Becker RC, Berger PB, Bhatt DL, Eikelboom JW, Konkle B, Mohler ER, Reilly MP, Berger JS. Mean platelet volume as a predictor of cardiovascular risk: A systematic review and meta-analysis. J Thromb Haemost 2010; 8: 148–156
- Gasparyan AY, Ayvazyan L, Mikhailidis DP, Kitas GD. Mean platelet volume: A link between thrombosis and inflammation?. Curr Pharm Des 2011; 17: 47–58
- Gasparyan AY, Sandoo A, Stavropoulos-Kalinoglou A, Kitas GD. Mean platelet volume in patients with rheumatoid arthritis: The effect of anti-TNF-α therapy. Rheumatol Int 2010; 30: 1125–1129
- Gasparyan AY, Stavropoulos-Kalinoglou A, Toms TE, Douglas KM, Kitas GD. Association of mean platelet volume with hypertension in rheumatoid arthritis. Inflamm Allergy Drug Targets 2010; 9: 45–50